Saturday, February 29 (26)

11:15 AM–12:15 PM

Opioid Therapy 2020: Past, Present, and Future (306)

This session will discuss the challenges surrounding the safe and effective use of opioids in chronic noncancer and cancer pain populations. An update on current evidence on opioid efficacy for chronic noncancer pain will be provided. Opioid treatment guidelines will be reviewed. Additional methods to mitigate risk will be described.

Opioid Safety: Still in Search of the Holy Grail for Low-Abuse-Potential Opioids

ToNhu Vu

Guidelines, Regulations, and Recommendations: Cancer and Non-Cancer Pain

Halena Gazelka

The Role of Opioids in Chronic Pain Management: Assessing the Evidence

David Provenzano

Learning Objectives:

  • Define opioid guidelines for cancer and chronic pain.
  • Employ methods to mitigate risk when using opioids.
  • Characterize current evidence for opioid efficacy in noncancer chronic pain.
Co-Presenters:

Halena Gazelka

ToNhu Vu

Moderator:

David Provenzano

11:15 AM–12:15 PM

Neuromodulation Review 2 (305)

With the fact that chronic pain afflicts more than 100 million Americans and amid the current opioid crisis, there is great unmet need for innovative alternatives for the treatment of chronic pain.

This session will report on a multicenter, prospective, randomized, double-blind study of this novel SCS system and will also focus on the value of ECAP monitoring to understand the mechanism of action of SCS as well provide neurophysiologic monitoring of spinal cord function.

Advances in using SCS for the management of cancer-related pain with emphasis on recognizing and mitigating possible complications will also be addressed.

Outcomes of Clinical Trials of SCS using ECAPS to Provide Closed-Loop Control

Nagy Mekhail, MD PhD

ECAPS for Neuro-Monitoring

Steven Falowski, MD

Advances in the Use of Spinal Cord Stimulation in the Treatment of Cancer-Related Pain

Lisa Stearns, MD

Learning Objectives:

  • Review the shortfalls of the current ‘fixed output' spinal cord stimulation technology.
  • Appraise the value of measuring the Evoked Compound Action Potential ‘ECAP’ as indicator/monitor of spinal cord activation.
  • Discuss the value and long-term outcomes of spinal cord stimulation for cancer-related pain.
9:15 AM–10:15 AM

Deconstructing Pelvic Pain: Differential Diagnosis and Interdisciplinary Treatment (304)

Chronic pelvic pain affects 15% of women ages 18 to 50 years old. An interactive problem-based learning discussion with multidisciplinary speakers will review the broad differential diagnoses of pelvic pain, discuss appropriate specialist referral, and identify evidence-based strategies for pelvic pain management.

Diagnosing and Treating Pelvic Pain: Pain Medicine Perspectives

Jennifer Hah

Diagnosing and Treating Pelvic Pain: Urogynecologic Perspectives

Marian G. Acevedo Alvarez

Treating Pelvic Pain: Psychosocial Perspectives

Ravi Prasad

Learning Objectives:

  • Differentiate bladder pain syndrome/interstitial cystitis from a myriad of other pelvic pain conditions including endometriosis, vulvodynia, and peripheral nerve entrapments.
  • Identify the role(s) of various specialists (e.g., pain medicine specialist, urologist, pain psychologist, and physical therapist) in the evidence-based interdisciplinary treatment of pelvic pain.
Subscribe to this RSS feed